362 studies found for:    "Sickle cell anemia"
Show Display Options
Rank Status Study
1 Terminated Effects of HQK-1001 in Patients With Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Sickle Cell Disorders;   Hemoglobin S Disease;   Sickling Disorder Due to Hemoglobin S
Interventions: Drug: HQK-1001;   Drug: Placebo
2 Completed A Study of HQK-1001 in Patients With Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Sickle Cell Disorders;   Hemoglobin S Disease;   Sickling Disorder Due to Hemoglobin S
Intervention: Drug: HQK-1001
3 Recruiting Microvascular Blood Flow in Sickle Cell Anemia
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Interventions: Drug: regadenoson infusion with contrast-enhanced ultrasound;   Procedure: contrast-enhanced ultrasound
4 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia;   Sickle Cell Disease
Intervention:
5 Completed A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Interventions: Drug: Low Dose ICA-17043;   Drug: High dose ICA-17043;   Drug: Placebo
6 Not yet recruiting Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   SCD
Interventions: Drug: Fludarabine;   Procedure: Hematopoietic Stem Cell Transplant (HSCT)
7 Not yet recruiting A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: N-Acetylcysteine
8 Withdrawn Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
9 Recruiting Gene Transfer for Patients With Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Genetic: Gene transfer using a gamma-globin lentivirus vector
10 Terminated A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: ICA-17043
11 Not yet recruiting Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: hydroxyurea
12 Recruiting Sickle Cell Disease - Stroke Prevention in Nigeria Trial
Conditions: Sickle Cell Anemia;   Sickle Cell Disease;   Stroke
Intervention: Drug: Hydroxyurea
13 Enrolling by invitation Blood Sampling for Research Related to Sickle Cell Disease
Conditions: Sickle Cell Trait;   Sickle Cell Disease;   Sickle Cell Anemia
Intervention:
14 Recruiting Carbon Monoxide Levels and Sickle Cell Disease Severity
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Anemia, Sickle Cell
Intervention:
15 Recruiting Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: vorinostat
16 Completed Safety Study of MP4CO in Adult Sickle Cell Patients
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
17 Unknown  A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Conditions: Sickle Cell Disease;   HEMOGLOBIN SS;   Hemoglobin S Beta-0 Thalassemia;   Inflammation;   Quality of Life
Interventions: Dietary Supplement: Omega-3 Fatty Acids: Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA);   Other: Placebo Capsules
18 Completed L-Glutamine Therapy for Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Thalassemia
Interventions: Drug: L-Glutamine;   Drug: Placebo
19 Completed Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Hydroxyurea;   Drug: L-Arginine;   Drug: Sildenafil
20 Recruiting Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Conditions: Sickle Cell Disease;   Hb-SS Disease With Vasoocclusive Pain;   Hemoglobin SS Disease With Vasoocclusive Crisis;   Other Sickle Cell Disease With Vaso-Occlusive Pain;   Hemoglobin SS Disease With Crisis
Interventions: Drug: Abciximab;   Drug: Placebo;   Other: Intravenous hydration;   Drug: Ibuprofen;   Drug: Parenteral narcotic;   Other: Incentive spirometry;   Other: Supplemental oxygen

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years